Furthermore, an alternate VLA-4 ligand, namely VCAM-1, is expressed selectively on RA endothelium and macrophages in the lining layer of the synovium, and is inhibited following anti-TNF-α therapy in the clinic [35]. Here, VCAM1 is linked to rheumatoid arthritis.